share_log
Moomoo 24/7 ·  03/11 07:38

NLS Pharmaceutics Has Been Notified By The Listing Qualifications Department Of The Nasdaq Stock Market That The Company's Plan To Regain Compliance Submitted On February 23, 2024 Has Been Approved

纳斯达克股票市场上市资格部门已通知NLS Pharmaceutics,该公司于2024年2月23日提交的恢复合规计划已获得批准

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发